The RCMI Center for Cancer Research established through NIH/NIMHD's RCMI program will continue to be a critical support mechanism in driving Xavier's efforts to enhance and expand its biomedical research capabilities. As stated in Section 1, the primary goal of the RCMI is to enhance faculty and programmatic research competitiveness, especially as related to the areas of cancer, minority health disparities and translational research. The Administrative Core will achieve this goal through the following aims:
Aim 1. To provide effective leadership in governing, monitoring and guiding the key activities of the RCMI program;
Aim 2. To provide user-friendly assistance in developing successful proposals for external support and to patent and license intellectual property;
Aim 3. To engage in strategic planning for ongoing development of the RCMI program and coordinate the effort with the University's strategic planning process.
Aim 4. To promote and facilitate the development of a cohesive group of faculty committed to being actively engaged in health disparities and translational research. The Administrative Core will consist of two Pis: Dr. Gene D'Amour and Dr. Guangdi Wang. Dr. Wang will also serve as the Program Director. In addition, there will be two Associate PDs, a Program Advisor/Consultant, and a Program Manager. The Administrative Core members will meet monthly with the Activity Leaders including the Core Directors and Co-Directors to review progress, identify problems, discuss and implement solutions and improvement plans to ensure that each specific aim is achieved as measured by assessment milestones.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
2G12MD007595-06
Application #
8845382
Study Section
Special Emphasis Panel (ZMD1-MLS (01))
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$1,193,274
Indirect Cost
$272,748
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Zhang, Xiaojie; Wang, Rubing; Perez, German Ruiz et al. (2016) Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents. Bioorg Med Chem 24:4692-700
Schroeder, Richard L; Tram, Phan; Liu, Jiawang et al. (2016) Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome P450 inhibition: a patent evaluation WO2015048311 (A1). Expert Opin Ther Pat 26:139-47
Vanden Eynde, Jean J; Mayence, Annie; Mottamal, Madhusoodanan et al. (2016) Alkanediamide-Linked Bisbenzamidines Are Promising Antiparasitic Agents. Pharmaceuticals (Basel) 9:
Crespo-Salgado, Janice; Vehaskari, V Matti; Stewart, Tyrus et al. (2016) Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome 4:50
Carriere, Patrick P; Llopis, Shawn D; Naiki, Anna C et al. (2016) Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1. Int J Environ Res Public Health 13:ijerph13010010
Vue, Bao; Zhang, Sheng; Zhang, Xiaojie et al. (2016) Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations. Eur J Med Chem 109:36-46
Zhang, Sheng; Vue, Bao; Huang, Michael et al. (2016) 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells. Bioorg Med Chem Lett 26:3226-31
Li, Xiang; Chen, Guanglin; Zhang, Xiaojie et al. (2016) A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models. Bioorg Med Chem Lett 26:4241-5
Schexnayder, Chandler; Stratford, Robert E (2016) Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells. Int J Environ Res Public Health 13:ijerph13010017
Mei, Suyu; Zhang, Kun (2016) Multi-label â„“2-regularized logistic regression for predicting activation/inhibition relationships in human protein-protein interaction networks. Sci Rep 6:36453

Showing the most recent 10 out of 104 publications